Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review
Open Access
- 19 March 2020
- Vol. 56 (3), 138
- https://doi.org/10.3390/medicina56030138
Abstract
Alarmins are endogenous mediators released by cells following insults or cell death to alert the host’s innate immune system of a situation of danger or harm. Many of these, such as high-mobility group box-1 and 2 (HMGB1, HMGB2) and S100 (calgranulin proteins), act through RAGE (receptor for advanced glycation end products), whereas the IL-1 and IL-33 cytokines bind the IL-1 receptors type I and II, and the cellular receptor ST2, respectively. The alarmin family and their signal pathways share many similarities of cellular and tissue localization, functions, and involvement in various physiological processes and inflammatory diseases including osteoporosis. The aim of the review was to evaluate the role of alarmins in osteoporosis. A bibliographic search of the published scientific literature regarding the role of alarmins in osteoporosis was organized independently by two researchers in the following scientific databases: Pubmed, Scopus, and Web of Science. The keywords used were combined as follows: “alarmins and osteoporosis”, “RAGE and osteoporosis”, “HMGB1 and osteoporosis”, “IL-1 and osteoporosis”, “IL 33 and osteopororsis”, “S100s protein and osteoporosis”. The information was summarized and organized in the present review. We highlight the emerging roles of alarmins in various bone remodeling processes involved in the onset and development of osteoporosis, as well as their potential role as biomarkers of osteoporosis severity and progression. Findings of the research suggest a potential use of alarmins as pharmacological targets in future therapeutic strategies aimed at preventing bone loss and fragility fractures induced by aging and inflammatory diseases.Keywords
This publication has 109 references indexed in Scilit:
- S100 proteins in cartilage: Role in arthritisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer diseaseJCI Insight, 2012
- Role of IL-33 in inflammation and diseaseJournal of Inflammation, 2011
- IL-33 family members and asthma – bridging innate and adaptive immune responsesCurrent Opinion in Immunology, 2010
- Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytesCellular and Molecular Life Sciences, 2010
- Therapeutic potential of HMGB1-targeting agents in sepsisExpert Reviews in Molecular Medicine, 2008
- High-Mobility Group Box Proteins Modulate Tumor Necrosis Factor-α Expression in Osteoclastogenesis via a Novel Deoxyribonucleic Acid SequenceMolecular Endocrinology, 2008
- Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral OssificationMolecular and Cellular Biology, 2007
- Structural and functional insights into RAGE activation by multimeric S100BThe EMBO Journal, 2007
- Proinflammatory S100 proteins in arthritis and autoimmune diseaseArthritis & Rheumatism, 2004